logo
Plus   Neg
Share
Email

AstraZeneca Says Imfinzi Approved In China For Stage III NSCLC - Quick Facts

AstraZeneca (AZN,AZN.L) announced that Imfinzi has been approved in China for the treatment of unresectable, Stage III non-small cell lung cancer based on the Phase III PACIFIC trial.

The approval of Imfinzi is based on results from the primary analysis of progression-free survival and supported by overall survival from the Phase III PACIFIC trial. Results showed a statistically significant and clinically meaningful OS and PFS benefit for treatment with Imfinzi vs. placebo after concurrent chemotherapy and radiation therapy.

Imfinzi reduced the risk of death by 32% and prolonged the time patients lived without disease progression or death by more than 11 months.

Dave Fredrickson, Executive Vice President, Oncology Business Unit said, "This approval illustrates our long-standing commitment to improving health outcomes in China, where more than one-third of the world's lung cancer diagnoses and deaths occur. As the global standard of care in this curative-intent setting, Imfinzi is an important new option for patients in China."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. said it is probing into the hack of its fourth-quarter earnings report that prompted the chipmaker to release its earnings statement ahead of schedule. The company, which was scheduled to release the results after the market closed, released it before the market closing on Thursday. Google parent Alphabet decided to drop its Internet balloon project Loon that was launched with the idea of providing Internet access to rural areas and providing last mile connectivity. In a blog post, Loon CEO Alastair Westgarth said they have not found a way to get the costs low enough to build a long-term, sustainable business, despite gaining a number of interested partners along the way. American Airlines announced the launch of Flagship Cellars, its home delivery service for premium wines usually available onboard. The airline's move is said to be due to the excess wine it has amid the weakness in air travel demand following the coronavirus pandemic crisis. The company expects the new at-home wine program to generate about $40,000 to $50,000 in sales during the first quarter.
Follow RTT